PAVM
Moldx to Convene Expert Medical Panel on Medicare Local Coverage Determination (Lcd) for Lucid Diagnostics' Esoguard® Esophageal DNA Test
时间:2025-07-16 19:31:03 市场: 美股 综合
PAVmed Inc: Files for Mixed Shelf Offering of up to $125 Mln
时间:2024-12-21 06:17:42 市场: 美股 综合
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million Nih Grant to Enhance Cancer Care
时间:2024-10-10 19:51:03 市场: 美股 综合
PAVmed Announces Efforts to Regain Compliance With Nasdaq Listing Requirements
时间:2024-09-17 04:30:03 市场: 美股 综合
PAVmed Inc - Determined That Lucid Diagnostics Inc and Its Subsidiaries Will Be Deconsolidated From Co's Financial Statements as of Sept 10
时间:2024-09-17 04:08:09 市场: 美股 综合